Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
The British Journal of Dermatology
|
May 21, 2021
Single-cell RNA sequencing profiling in a patient with discordant primary cutaneous B-cell and T-cell lymphoma reveals micromilieu-driven immune skewing
C Jonak, N Alkon, K Rindler, et al.
Scientific Reports
|
March 27, 2024
Author Correction: Real-world effectiveness of anti-interleukin-23 antibodies in chronic plaque-type psoriasis of patients from the Austrian Psoriasis Registry (PsoRA)
T Graier, W Weger, C Jonak, et al.
Scientific Reports
|
September 5, 2022
Real-world effectiveness of anti-interleukin-23 antibodies in chronic plaque-type psoriasis of patients from the Austrian Psoriasis Registry (PsoRA)
T Graier, W Weger, C Jonak, et al.
The British Journal of Dermatology
|
June 17, 2021
Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity
E Papadavid, E Kapniari, V Pappa, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 20, 2020
Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study
M-C Brüggen, J Valencak, R Stranzenbach, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 27, 2024
Health-related quality of life and its influencing factors in patients with primary cutaneous B-cell lymphomas: A multicentric study in 100 patients
A E C Schirren, J D Albrecht, S Melchers, et al.
The British Journal of Dermatology
|
December 8, 2020
Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysis
T Graier, W Salmhofer, C Jonak, et al.
The British Journal of Dermatology
|
May 4, 2019
Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study
K Molloy, C Jonak, F J S H Woei-A-Jin, et al.
The British Journal of Dermatology
|
June 24, 2020
Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study
E Hodak, S Sherman, E Papadavid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 28, 2018
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium
P Quaglino, M Maule, H M Prince, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
The British Journal of Dermatology
|
May 21, 2021
Single-cell RNA sequencing profiling in a patient with discordant primary cutaneous B-cell and T-cell lymphoma reveals micromilieu-driven immune skewing
C Jonak, N Alkon, K Rindler, et al.
Scientific Reports
|
March 27, 2024
Author Correction: Real-world effectiveness of anti-interleukin-23 antibodies in chronic plaque-type psoriasis of patients from the Austrian Psoriasis Registry (PsoRA)
T Graier, W Weger, C Jonak, et al.
Scientific Reports
|
September 5, 2022
Real-world effectiveness of anti-interleukin-23 antibodies in chronic plaque-type psoriasis of patients from the Austrian Psoriasis Registry (PsoRA)
T Graier, W Weger, C Jonak, et al.
The British Journal of Dermatology
|
June 17, 2021
Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity
E Papadavid, E Kapniari, V Pappa, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 20, 2020
Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study
M-C Brüggen, J Valencak, R Stranzenbach, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 27, 2024
Health-related quality of life and its influencing factors in patients with primary cutaneous B-cell lymphomas: A multicentric study in 100 patients
A E C Schirren, J D Albrecht, S Melchers, et al.
The British Journal of Dermatology
|
December 8, 2020
Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysis
T Graier, W Salmhofer, C Jonak, et al.
The British Journal of Dermatology
|
May 4, 2019
Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study
K Molloy, C Jonak, F J S H Woei-A-Jin, et al.
The British Journal of Dermatology
|
June 24, 2020
Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study
E Hodak, S Sherman, E Papadavid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 28, 2018
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium
P Quaglino, M Maule, H M Prince, et al.
Page
of 4